References
- Klinefelter HF, Reifenstein EC, Albright F. Syndrome characterized by gynecomastia, aspermatogenesis without aleydigism and increased excretion of follicle-stimulating hormone. J Clin Endocrinol 1942; 2:615 - 627
- Veraart JC, Hamulyak K, Neumann HA, et al. Increased plasma activity of plasminogen activator inhibitor (PAI-1) in two patients with Klinefelter's syndrome complicated by leg ulcers. Br J Dermatol 1994; 130:641 - 644
- Ibbotson SH, Layton AM, Davies JA, et al. Plasminogen activator inhibitor 1 (PAI-1) levels in patients with chronic venous leg ulceration. Br J Dermatol 1994; 131:738 - 739
- Veraart JC, Hamulyak K, Neumann HA. Klinefelter's syndrome as a model for skin changes in venous insufficiency. Wien Med Wochenschr 1994; 144:277 - 278
- Villemur B, Truche H, Pernod G, et al. Leg ulcer and Klinefelter syndrome. J Mal Vasc 1995; 20:215 - 218
- Aollner T, Veraart J, Wolter M, et al. Leg ulcers in Klinefelter's syndrome—further evidence for an involvement of plasminogen activator inhibitor-1. Br J Dermatol 1997; 136:341 - 344
- Igawa K, Nishioka K. Leg ulcer in Klinefelter's syndrome. J Eur Acad Dermatol Venereol 2003; 17:62 - 64
- De Morentin HM, Dodiuk-Gad RP, Brenner S. Klinefelter's Syndrome presenting with leg ulcers. Skinmed 2004; 3:274 - 278
- Gattringer C, Scheurecker C, Höpfl R, Müller H. Association between venous leg ulcers and sex chromosome anomalies in men. Acta Derm Venereol 2010; 90:612 - 615